Article
An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells
17 Mar 2016
Abstract excerpt
Radiotherapy is a mainstay of curative prostate cancer treatment, but risks of recurrence after treatment remain significant in locally advanced disease. Given that tumor relapse can be attributed to a population of cancer stem cells (CSC) that survives radiotherapy, analysis of this cell population might illuminate tactics to personalize treatment. However, this direction remains challenging given the plastic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
